Nutritional Status Is Not a Predictor of Anaphylaxis Severity in a Pediatric Cohort: A Retrospective Analysis

Izabela Kucharek1, Krzysztof Przystał-Dyszyński1, Aleksandra Godyńska1

  • 1Clinical Department of Pediatrics and Allergology, National Medical Institute of the Ministry of the Interior and Administration, 02-507 Warsaw, Poland.

Nutrients
|September 27, 2025
PubMed

Insights

Childhood obesity does not predict anaphylaxis severity in children. This study found no link between Body Mass Index (BMI) and severe allergic reactions in hospitalized youth, unlike in adults.

Area of Science:

  • Pediatric Allergy and Immunology
  • Nutritional Science
  • Public Health

Background:

  • Childhood obesity is a pro-inflammatory state linked to worse outcomes in allergic diseases like asthma.
  • In adults, obesity is a risk factor for severe anaphylaxis, but this association is unclear in children.

Purpose of the Study:

  • To investigate the relationship between Body Mass Index (BMI) and the severity and presentation of anaphylaxis in hospitalized children.
  • To determine if nutritional status influences anaphylaxis outcomes in pediatric patients.

Main Methods:

  • Retrospective analysis of 199 hospitalized children (0-18 years) with anaphylaxis.
  • Categorization of nutritional status using Body Mass Index (BMI): underweight, normal weight, overweight, and obese.
  • Assessment of anaphylaxis severity using World Allergy Organization (WAO) grading and analysis of clinical presentation across BMI groups.

Main Results:

  • No statistically significant association was found between BMI categories and anaphylaxis severity (p = 0.861).
  • Severe anaphylactic reactions (WAO grades 4-5) were infrequent across all BMI groups.
  • Adjusted regression analyses indicated BMI was not an independent predictor of anaphylaxis severity or organ system involvement in children.

Conclusions:

  • Nutritional status, as measured by BMI, does not predict anaphylaxis severity or presentation in this pediatric cohort.
  • The role of obesity as a risk factor for severe anaphylaxis may be age-dependent, differing between children and adults.
  • Findings suggest caution when extrapolating adult anaphylaxis data to pediatric populations.

Related Concept Videos

Allergic Reactions02:06

Allergic Reactions

Overview
32.0K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
246
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
254
Allergic Drug Reactions01:27

Allergic Drug Reactions

Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
1.3K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
193
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
212